"fascinated by robotics in health care"

Maarten Steinbuch, a professor at Eindhoven University of Technology, is fascinated by robotics in health care. 

He is convinced that in our region we can develop sufficient precision technology to make a significant contribution to robotics in health care. 

Photo: Preceyes
Spinout companies

Within that context, several spinout companies have been founded to bring new medical robotic technologies to the market, of which Microsure and Preceyes (see photo) are very good examples.

These start-ups are usually initiated with young engineers, who subsequently all have to learn how to run a business. 

Moreover, they would be looking at the same funding opportunities and therefore compete with each other.

"relieve the engineers"

To allow the engineers to focus on improving their technology, the concept of a single company with several business divisions was considered. In that concept, the company would be run by experts to relieve the engineers.

Anupam Nayak and Maarten Steinbuch
Eindhoven Medical Robotics

For professor Steinbuch this was cause to team up with Anupam Nayak, who has a Philips background and wide experience with the ‘business side’, and start an umbrella organisation together:

Eindhoven Medical Robotics

Eindhoven Medical Robotics (EMR) was started up in business units. One of the units in EMR develops an electric steering mechanism to be applied to catheters:

an electric steering mechanism to be applied to catheters
"an electric steering mechanism to be applied to catheters"

The mechanism allows catheters inside the body to be guided more easily from outside the body and allow for controlling the tip of the catheter to perform interventions once it has been placed in the correct location. 

This adds great extra value to several cardiovascular applications, and the first targeted application is ‘ablation’ of the heart’s atria. It’s a procedure aimed at solving cardiac arrhythmia

One of the researchers in this project is Rolf Gaasbeek from Eindhoven Medical Robotics. A second researcher will be added to the R&D team for this project. (see: vacancies)

LifeTec Group - PhysioHeart RnD platform
test ‘how well the tissue is damaged’

LifeTec Group has (lifelike, lab-animal free) heart platforms such as the Cardiac Biosimulator or the PhysioHeart™ for testing this application with respect to navigation inside the heart and the formation of scar tissue (the aim of ablation).

"Ideally you’d want to test ‘how well the tissue is damaged’, and potentially also how it changes the electrophysiology of the heart (so the arrhythmia itself)" LifeTec Group's Head of Medtech Innovation Marco Stijnen says.

LifeTec Group is extremely well equipped on the subject of heart platforms. Customization of these platforms according to the needs of specific applications is more or less standard procedure at LifeTec Group. 

To assess the navigation of the smart catheter from insertion into the body until it is located in the heart, more is needed than only a heart.

The challenge for LifeTec Group’s part of this project is therefore in vascular access: creating a realistic vascular model that offers access to the heart. In doing so the company explores various techniques, from 3D printing to studying human cadavers. 

Please do not hesitate to contact Marco Stijnen if you require any further information:

Head of MedTech Innovation
Marco Stijnen
Call at +31 40 298 93 93 or e-mail us

Relevant platforms:

- Cardiac Biosimulator [Link]

- PhysioHeart™ [Link]

- Vascular Bioreactor [Link]

Search query: 

- 'cardiovascular' on this website [Link]

©2020 LifeTec Group.  Legal  Credits